$2.75
-0.04-1.61%
At Close: -
$2.70
-0.04-1.64%
After Hours: 5:30 PM EDT
15 minutes delayed
Comments
Loading...
GT Biopharma
GTBPNASDAQ
GT Biopharma (NASDAQ:GTBP) Stock, Earnings Estimates, EPS, And Revenue
GT Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 15
EPS
$-1.640
Quarterly Revenue
$0K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of GT Biopharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GTBP | GT Biopharma | -$1.50 | — | — | — | $0.00 | — | — | — | 08/05/2024 | Get Alert |
| GTBP | GT Biopharma | -$0.21 | -$2.70 | -$1.64 | 39.26% | $0.00 | — | $0.00 | — | 05/15/2024 | Get Alert |
| GTBP | GT Biopharma | -$5.40 | -$2.70 | -$2.14 | 20.74% | $0.00 | — | $0.00 | — | 03/26/2024 | Get Alert |
| GTBP | GT Biopharma | -$6.60 | -$3.00 | -$1.80 | 40.00% | $0.00 | — | $0.00 | — | 11/01/2023 | Get Alert |
| GTBP | GT Biopharma | -$3.00 | -$3.00 | -$1.50 | 50.00% | $0.00 | — | $0.00 | — | 08/07/2023 | Get Alert |
| GTBP | GT Biopharma | -$5.10 | -$4.20 | -$0.30 | 92.86% | $0.00 | — | $0.00 | — | 05/15/2023 | Get Alert |
| GTBP | GT Biopharma | -$15.60 | -$5.10 | -$5.40 | -5.88% | $0.00 | — | $0.00 | — | 03/30/2023 | Get Alert |
| GTBP | GT Biopharma | -$5.10 | -$3.30 | -$6.60 | -100.00% | $0.00 | — | $0.00 | — | 10/31/2022 | Get Alert |
| GTBP | GT Biopharma | -$4.50 | -$0.17 | -$3.00 | -1664.71% | $0.00 | — | $0.00 | — | 08/11/2022 | Get Alert |
| GTBP | GT Biopharma | -$54.90 | -$9.30 | -$5.10 | 45.16% | $0.00 | — | $0.00 | — | 05/16/2022 | Get Alert |
| GTBP | GT Biopharma | -$102.00 | -$6.30 | -$15.60 | -147.62% | $0.00 | — | $0.00 | — | 03/28/2022 | Get Alert |
| GTBP | GT Biopharma | -$19.20 | -$6.30 | -$5.10 | 19.05% | $0.00 | — | $0.00 | — | 11/10/2021 | Get Alert |
| GTBP | GT Biopharma | — | -$8.40 | -$4.50 | 46.43% | — | — | $0.00 | — | 08/23/2021 | Get Alert |
| GTBP | GT Biopharma | — | — | -$54.90 | — | — | — | $0.00 | — | 05/17/2021 | Get Alert |
| GTBP | GT Biopharma | — | -$7.20 | -$102.00 | -1316.67% | — | — | $0.00 | — | 04/19/2021 | Get Alert |
GT Biopharma (GTBP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-15 | $-1.64 | $-2.70 | 39.3 % |
| Dec 2023 | 2024-03-26 | $-2.14 | $-2.70 | 20.7 % |
| Sep 2023 | 2023-11-01 | $-1.80 | $-3.00 | 40.0 % |
| Jun 2023 | 2023-08-07 | $-1.50 | $-3.00 | 50.0 % |
GT Biopharma (GTBP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is GT Biopharma (NASDAQ:GTBP) reporting earnings?
GT Biopharma (GTBP) is scheduled to report earnings on August 5, 2024. The last reported earnings were for reported on May 15, 2024 for Q1.
What were the latest earnings per share (EPS) for GT Biopharma (NASDAQ:GTBP)?
The Actual EPS was $-1.64, which beat the estimate of $-2.70.
What were GT Biopharma’s (NASDAQ:GTBP) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.